M&A: To Deal or Not to Deal

In a capital constrained environment, some might argue that now is not the time for businesses to be pursuing growth via M&A. Others might posit that the best deals are struck at weak points in the economic cycle. Senior Editor Jacob Ambrose Willson asks Criticaleye Members for their views on executing M&A in 2023 and beyond.

Featuring Commentary From:

Michel Driessen, Senior Partner, Strategy and Transactions, EY
Alastair Mills, Managing Director & Head of European Business Services, H.I.G. Capital
Michael Teixeira, CEO, MVF
Helen Wiseman, Chair, Elixinol Wellness




Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
Growth in a High-octane Lands...

Speakers at Criticaleye’s recent Growth Company Retreat discuss the multiple pressures bearing down on leaders at present, and how to maintain a course to growth in a frenetic environment. Featuring commenta...

Click here to download this insight
Navigating Growth: CFOs at th...

The CFO of a growth company is tasked with laying out the financial pathway to support its growth objectives. This involves fundraising, capital allocation and reporting, but nowadays the role is much broader. Criticale...

Click here to download this insight
True Diligence - Research Fin...

With increasing pressure on businesses to ‘do no harm’, leaders need to ask themselves: ‘what do we want to stand for as a business’? In the report based on opinion research from 1,200 C-Sui...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 1,500




Amazon UK E.ON UK Lightsource bp Robert Walters Eton Bridge Partners Workday Concentrix Tullow Oil plc LDC Accenture Google Redwood Bank Royal London Group NATS GlaxoSmithKline plc Veolia Water Technologies Drax Group plc London Stock Exchange Mayborn Group Legal & General Investment Management Bunzl plc